ArticleCell reports. Medicine2024

Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders.

Jiaying Toh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.